The presence of viral subpopulations in an infectious bronchitis virus vaccine with differing pathogenicity - A preliminary study

Vaccine

Volumn 30, Issue 28, 2012, Pages 4190-4199

  Hewson, Kylie A ^a   Scott, Peter C ^a,b   Devlin, Joanne M ^a   Ignjatovic, Jagoda ^a   Noormohammadi, Amir H ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b Scolexia Pty Ltd   (Australia)

Author keywords

Coronavirus; Infectious bronchitis virus; Pathogenicity; Subpopulation; Vaccine

Indexed keywords

AVIAN INFECTIOUS BRONCHITIS VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUSTRALIA; AVIAN INFECTIOUS BRONCHITIS; AVIAN INFECTIOUS BRONCHITIS VIRUS; CHICK EMBRYO; CONTROLLED STUDY; EMBRYO; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VIROGENESIS; VIRUS ISOLATION; VIRUS TITRATION; VIRUS VIRULENCE;

3' UNTRANSLATED REGIONS; ANIMALS; AUSTRALIA; CHICK EMBRYO; CHICKENS; CORONAVIRUS INFECTIONS; GENOTYPE; INFECTIOUS BRONCHITIS VIRUS; POULTRY DISEASES; RNA, VIRAL; VIRAL LOAD; VIRAL VACCINES; VIRULENCE; VIRUS REPLICATION;

EID: 84861652803     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.04.054     Document Type: Article

References (65)

1. Cavanagh D. Coronavirus avian infectious bronchitis virus. Veterinary Research 2007, 38(2):281-297.
2. Cavanagh D., Naqi S.A. Infectious bronchitis. Diseases of poultry 2003, 101-119. Iowa State Press, Ames, Iowa. Y.M. Saif, H.J. Barnes, J.R. Glisson, A.M. Fadly, L.R. McDougald, D.E. Swayne (Eds.).
3. Ignjatovic J., Ashton D.F., Reece R., Scott P., Hooper P. Pathogenicity of Australian strains of avian infectious bronchitis virus. Journal of Comparative Pathology 2002, 126(2-3):115-123.
4. Jackwood M.W., Hilt D.A., Williams S.M., Woolcock P.R., Cardona C., O'Connor R. Molecular and serologic characterization, pathogenicity, and protection studies with infectious bronchitis virus field isolates from California. Avian Diseases 2007, 51(2):527-533.
5. Schalk A.F., Hawn M.C. An apparently new respiratory disease of baby chicks. Journal of the American Veterinary Medical Association 1931, 78:413-422.
6. Winterfield R.W., Fadly A.M., Hoerr F.J. Immunity to infectious bronchitis virus from spray vaccination with derivatives of a Holland strain. Avian Diseases 1976, 20(1):42-48.
7. Ratanasethakul C., Cumming R.B. Immune response of chickens to various routes of administration of Australian infectious bronchitis vaccine. Australian Veterinary Journal 1983, 60(7):214-216.
8. Gelb J., Lunt R.L., Metz A.L., Fries P.A. Attenuation of avian infectious bronchitis virus by cold-adaptation. Avian Diseases 1991, 35(4):847-853.
9. Sander J.E., Jackwood M.W., Rowland G.N. Protection by a commercial Arkansas-type infectious bronchitis virus vaccine against a field isolate of the same serotype. Avian Diseases 1997, 41(4):964-967.
10. Cook J.K., Orbell S.J., Woods M.A., Huggins M.B. Breadth of protection of the respiratory tract provided by different live-attenuated infectious bronchitis vaccines against challenge with infectious bronchitis viruses of heterologous serotypes. Avian Pathology 1999, 28(5):477-485.
11. Cook J.K., Chesher J., Baxendale W., Greenwood N., Huggins M.B., Orbell S.J. Protection of chickens against renal damage caused by a nephropathogenic infectious bronchitis virus. Avian Pathology 2001, 30(4):423-426.
12. Cook J.K., Smith H.W., Huggins M.B. Infectious bronchitis immunity: its study in chickens experimentally infected with mixtures of infectious bronchitis virus and Escherichia coli. Journal of General Virology 1986, 67(7):1427-1434.
13. Martins N.R., Mockett A.P., Barrett A.D., Cook J.K. IgM responses in chicken serum to live and inactivated infectious bronchitis virus vaccines. Avian Diseases 1991, 35(3):470-475.
14. Bijlenga G., Cook J.K., Gelb J., de Wit J.J. Development and use of the H strain of avian infectious bronchitis virus from the Netherlands as a vaccine: a review. Avian Pathology 2004, 33(6):550-557.
15. Ladman B.S., Pope C.R., Ziegler A.F., Swieczkowski T., Callahan J.M., Gelb J. Protection of chickens following live and inactivated virus vaccination against challenge with nephropathogenic infectious bronchitis virus PA/Wolgemuth/98. Avian Diseases 2002, 46:938-944.
16. Hopkins S.R., Yoder H.W. Reversion to virulence of chicken-passaged infectious bronchitis vaccine virus. Avian Diseases 1986, 30(1):221-223.
17. Estevez C., Villegas P., El-Attrache J. A recombination event, induced in ovo, between a low passage infectious bronchitis virus field isolate and a highly embryo adapted vaccine strain. Avian Diseases 2003, 47:1282-1290.
18. Wadey C.N., Faragher J.T. Australian infectious bronchitis viruses: identification of nine subtypes by a neutralisation test. Research in Veterinary Science 1981, 30:70-74.
19. Ignjatovic J., Gould G., Sapats S. Isolation of a variant infectious bronchitis virus in Australia that further illustrates diversity among emerging strains. Archives of Virology 2006, 151(8):1567-1585.
20. Sapats S.I., Ashton F., Wright P.J., Ignjatovic J. Sequence analysis of the S1 glycoprotein of infectious bronchitis viruses: identification of a novel genotypic group in Australia. Journal of General Virology 1996, 77(3):413-418.
21. Cumming RB Infectious bronchitis - a personal view. Australian Poultry Science Symposium 1994.
22. Cumming RB The etiology of uraemia of chickens. Australian Veterinary Journal 1962, 38(11):554.
23. Cumming R.B. Infectious avian nephrosis (uraemia) in Australia. Australian Veterinary Journal 1963, 39(4):145-147.
24. Newton L.G., Simmons G.C. Avian nephritis and uraemia. Australian Veterinary Journal 1963, 39(4):135-139.
25. Cumming R.B. The control of avian infectious bronchitis/nephrosis in Australia. Australian Veterinary Journal 1969, 45(4):200-203.
26. Chubb R.C., Wells B.A., Cumming R.B. Some immunological aspects of a recent Australian isolate of infectious bronchitis virus. Australian Veterinary Journal 1976, 52(8):378-381.
27. Mardani K., Noormohammadi A.H., Ignjatovic J., Browning G.F. Typing infectious bronchitis virus strains using reverse transcription-polymerase chain reaction and restriction fragment length polymorphism analysis to compare the 3' 7.5 kb of their genomes. Avian Pathology 2006, 35(1):63-69.
28. Koch G., Hartog L., Kant A., van Roozelaar D.J. Antigenic domains on the peplomer protein of avian infectious bronchitis virus: correlation with biological functions. Journal of General Virology 1990, 71(9):1929-1935.
29. Luo Z., Weiss S.R. Roles in cell-to-cell fusion of two conserved hydrophobic regions in the murine coronavirus spike protein. Virology 1998, 244(2):483-494.
30. Cavanagh D. Coronavirus IBV: structural characterization of the spike protein. Journal of General Virology 1983, 64(12):2577-2583.
31. Cavanagh D., Davis P.J. Evolution of avian coronavirus IBV: sequence of the matrix glycoprotein gene and intergenic region of several serotypes. Journal of General Virology 1988, 69(3):621-629.
32. Cavanagh D., Davis P.J., Cook J.K., Li D., Kant A., Koch G. Location of the amino acid differences in the S1 spike glycoprotein subunit of closely related serotypes of infectious bronchitis virus. Avian Pathology 1992, 21(1):33-43.
33. Kant A., Koch G., van Roozelaar D.J., Kusters J.G., Poelwijk F.A.J., van der Zeijst B.A. Location of antigenic sites defined by neutralizing monoclonal antibodies on the S1 avian infectious bronchitis virus glycopolypeptide. Journal of General Virology 1992, 73(3):591-596.
34. Boursnell M.E.G., Brown T.D., Foulds I.J., Green P.F., Tomley F.M., Binns M.M. Completion of the sequence of the genome of the coronavirus avian infectious bronchitis virus. Journal of General Virology 1987, 68(1):57-77.
35. Britton P., Casais R., Hodgson T., Davies M., Cavanagh D. Genes 3 and 5 of infectious bronchitis virus are accessory protein genes. Advances in Experimental Medicine and Biology 2006, 581:363-368.
36. Hodgson T., Britton P., Cavanagh D. Neither the RNA nor the proteins of open reading frames 3a and 3b of the coronavirus infectious bronchitis virus are essential for replication. Journal of Virology 2006, 80(1):296-305.
37. Cao J., Wu C.C., Lin T.L. Complete nucleotide sequence of polyprotein gene 1 and genome organization of turkey coronavirus. Virus Research 2008, 136(1-2):43-49.
38. Gomaa M.H., Barta J.R., Ojkic D., Yoo D. Complete genomic sequence of turkey coronavirus. Virus Research 2008, 135(2):237-246.
39. Hewson K.A., Ignjatovic J., Browning G.F., Devlin J.M., Noormohammadi A.H. Infectious bronchitis viruses with naturally occurring genomic rearrangement and gene deletion. Archives of Virology 2010, 156(2):245-252.
40. Biebricher C.K., Eigen M. The error threshold. Virus Research 2005, 107(2):117-127.
41. Eigen M. On the nature of virus quasispecies. Trends in Microbiology 1996, 4(6):216-218.
42. Eigen M. Viral quasispecies. Scientific American 1993, 269(1):42-49.
43. Enjuanes L., Sola I., Zuniga S., Moreno J.L. Coronavirus RNA synthesis: transcription. Coronaviruses: molecular and cellular biology 2007, 81-107. Caister Academic Press, Norfolk. V. Thiel (Ed.).
44. Lai M.M., Cavanagh D. The molecular biology of coronaviruses. Advances in Virus Research 1997, 1-100. Academic Press, San Diago, California. K. Maramorosch, A.J. Shatkin (Eds.).
45. Jackwood M.W., Hilt D.A., Callison S.A. Detection of infectious bronchitis virus by real-time reverse transcriptase-polymerase chain reaction and identification of a quasispecies in the Beaudette strain. Avian Diseases 2003, 47(3):718-724.
46. Zhang X., Hasoksuz M., Spiro D., Halpin R., Wang S., Vlasova A., et al. Quasispecies of bovine enteric and respiratory coronaviruses based on complete genome sequences and genetic changes after tissue culture adaptation. Virology 2007, 363(1):1-10.
47. Vignuzzi M., Stone J.K., Arnold J.J., Cameron C.E., Andino R. Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population. Nature 2006, 439(7074):344-348.
48. Mardani K., Browning G.F., Ignjatovic J., Noormohammadi A.H. Rapid differentiation of current infectious bronchitis virus vaccine strains and field isolates in Australia. Australian Veterinary Journal 2006, 84(1-2):59-62.
49. Hewson K.A., Noormohammadi A.H., Devlin J.M., Mardani K., Ignjatovic J. Rapid detection and non-subjective characterisation of infectious bronchitis virus isolates using high-resolution melt curve analysis and a mathematical model. Archives of Virology 2009, 154(4):649-660.
50. Jackwood D.J., Sommer S.E. Identification of infectious bursal disease virus quasispecies in commercial vaccines and field isolates of this double-stranded RNA virus. Virology 2002, 304(1):105-113.
51. McKinley E.T., Hilt D.A., Jackwood M.W. Avian coronavirus infectious bronchitis attenuated live vaccines undergo selection of subpopulations and mutations following vaccination. Vaccine 2008, 26(10):1274-1284.
52. Hitchner S.B. Virus propagation in embryonating eggs. Isolation and identification of avian pathogens 1980, Creative Printing Company, Endwell, New York. S.B. Hitchener, C.H. Domermuth, H.G. Purchase, J.E. Williams (Eds.).
53. Benson D.A., Karsch-Mizrachi I., Lipman D.J., Ostell J., Wheeler D.L. GenBank. Nucleic Acids Research 2008, 36:D25-D30.
54. Hewson K.A., Browning G.F., Devlin J.M., Ignjatovic J., Noormohammadi A.H. Application of high-resolution melt curve analysis for classification of infectious bronchitis viruses in field specimens. Australian Veterinary Journal 2010, 88(10):408-413.
55. Liao C.L., Lai M.M. Requirement of the 5'-end genomic sequence as an upstream cis-acting element for coronavirus subgenomic mRNA transcription. Journal of Virology 1994, 68(8):4727-4737.
56. Zhang X., Liao C.L., Lai M.M. Coronavirus leader RNA regulates and initiates subgenomic mRNA transcription both in trans and in cis. Journal of Virology 1994, 68(8):4738-4746.
57. Schultze B., Cavanagh D., Herrler G. Neuraminidase treatment of avian infectious bronchitis coronavirus reveals a hemagglutinating activity that is dependent on sialic acid-containing receptors on erythrocytes. Virology 1992, 189(2):792-794.
58. Ito T., Suzuki Y., Takada A., Kawamoto A., Otsuki K., Masuda H., et al. Differences in sialic acid-galactose linkages in the chicken egg amnion and allantois influence human influenza virus receptor specificity and variant selection. Journal of Virology 1997, 71(4):3357-3362.
59. Cavanagh D., Picault J.P., Gough R.E., Hess M., Mawditt K.L., Britton P. Variation in the spike protein of the 793/B type of infectious bronchitis virus, in the field and during alternate passage in chickens and embryonated eggs. Avian Pathology 2005, 34(1):20-25.
60. Delaplane J.P., Stuart H.O. The modification of infectious bronchitis virus of chickens as the result of propagation in embryonated chicken eggs. Rhode Island State College, Experiment Station Bulletin 1941, 284:5-15.
61. Gelb J., Cloud S.S. Effect of serial embryo passage of an Arkansas-type avian infectious bronchitis virus isolate on clinical response, virus recovery, and immunity. Avian Diseases 1983, 27(3):679-687.
62. Armesto M., Cavanagh D., Britton P. The replicase gene of avian coronavirus infectious bronchitis virus is a determinant of pathogenicity. PLoS ONE 2009, 4(10):e7384.
63. Williams G.D., Chang R.Y., Brian D.A. Evidence for a pseudoknot in the 3' untranslated region of the bovine coronavirus genome. Advances in Experimental Medicine and Biology 1995, 380:511-514.
64. Katz J.M., Webster R.G. Amino acid sequence identity between the HA1 of influenza A (H3N2) viruses grown in mammalian and primary chick kidney cells. Journal of General Virology 1992, 73(Pt 5):1159-1165.
65. Huang Y.P., Wang C.H. Sequence changes of infectious bronchitis virus isolates in the 3' 7.3 kb of the genome after attenuating passage in embryonated eggs. Avian Pathology 2007, 36(1):59-67.